ROIV
Price
$11.57
Change
+$0.07 (+0.61%)
Updated
Dec 20 closing price
57 days until earnings call
STOK
Price
$11.68
Change
+$0.38 (+3.36%)
Updated
Dec 20 closing price
73 days until earnings call
Ad is loading...

ROIV vs STOK

Header iconROIV vs STOK Comparison
Open Charts ROIV vs STOKBanner chart's image
Roivant Sciences
Price$11.57
Change+$0.07 (+0.61%)
Volume$16M
CapitalizationN/A
Stoke Therapeutics
Price$11.68
Change+$0.38 (+3.36%)
Volume$1.18M
CapitalizationN/A
ROIV vs STOK Comparison Chart
Loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROIV vs. STOK commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and STOK is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ROIV: $11.57 vs. STOK: $11.68)
Brand notoriety: ROIV and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 338% vs. STOK: 222%
Market capitalization -- ROIV: $8.42B vs. STOK: $618.65M
ROIV [@Biotechnology] is valued at $8.42B. STOK’s [@Biotechnology] market capitalization is $618.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • ROIV’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than STOK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 3 bullish TA indicator(s).

  • ROIV’s TA Score: 4 bullish, 5 bearish.
  • STOK’s TA Score: 3 bullish, 8 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than STOK.

Price Growth

ROIV (@Biotechnology) experienced а -2.28% price change this week, while STOK (@Biotechnology) price change was -3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

ROIV is expected to report earnings on Feb 17, 2025.

STOK is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.42B) has a higher market cap than STOK($619M). STOK YTD gains are higher at: 122.053 vs. ROIV (3.028).
ROIVSTOKROIV / STOK
Capitalization8.42B619M1,361%
EBITDAN/AN/A-
Gain YTD3.028122.0532%
P/E Ratio2.09N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ROIVSTOK
RSI
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.61%
IMVT - ROIV
59%
Loosely correlated
+0.78%
ARGX - ROIV
47%
Loosely correlated
-0.35%
RARE - ROIV
42%
Loosely correlated
+1.73%
STOK - ROIV
42%
Loosely correlated
+3.36%
FOLD - ROIV
40%
Loosely correlated
+0.72%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+3.36%
NUVB - STOK
52%
Loosely correlated
-0.37%
STRO - STOK
48%
Loosely correlated
+3.30%
INZY - STOK
46%
Loosely correlated
+6.41%
QTTB - STOK
44%
Loosely correlated
+7.49%
DNLI - STOK
43%
Loosely correlated
-0.19%
More